Guardant Health to Participate in Upcoming Investor Conferences
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/21/2026
- Wall St rises in broad rebound; yields push markets towards weekly declines
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Supermicro probe finds no senior management link to export violations
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Hertz Global amends voting agreement with CK Amarillo after lawsuit
- SpaceX shares fall as second lockup period ends
BTIG Reiterates Buy Rating on Guardant Health (GH)
May 23, 2024 5:54 AM EDTBTIG analyst Mark Massaro reiterated a Buy rating and $45.00 price target on Guardant Health (NASDAQ: GH).
The analyst comments "We think the stock valuation can tolerate slightly higher leverage above 6x, especially if odds improve for the yield curve to steepen... On... More
